Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MS.

Jens KuhleNadia DaizadehPascal BenkertAleksandra MaceskiChristian BarroZuzanna MichalakMaria Pia SormaniJean GodinSrinivas ShankaraTarek A SamadAlan JacobsLuke ChungNora RӧschCarina KaiserColin P MitchellDavid LeppertEvis HavariLudwig Kappos

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)

NCT00530348, NCT00930553, NCT02255656.

Keyphrases

multiple sclerosis
disease activity
mass spectrometry
cerebrospinal fluid
ms ms
rheumatoid arthritis